Joe Luis Diaz

Jose Luis joined AstraZeneca in November 2014 as part of the AZ acquisition of the Almirall respiratory portfolio. Since joining AZ he has been Global Project Manager for the aclidinium franchise, PT027, anifrolumab and nirsevimab, respectively. Before leading the Vaccines and Immune Therapies (V&I) Global Portfolio and Project Management, Jose Luis has been Senior Director of Late R&I Project Management and member of the Biopharma PM Leadership Team, chair of the Late R&I Resource Council and Site Head for AZ Barcelona.

Jose Luis received a BSc in microbiology from University College London and a PhD in Autoimmunity from the University of Southampton (UK). He has over 30 years’ experience in R&D, including 2 years in Glaxo and 8 years in USA Biotech companies before joining Almirall (Spain’s largest pharmaceutical company at the time) as Head of External Research.
Outside of AZ his passions include his 3 daughters, wine, military history and rugby (not necessarily in that order).